1-3 of 3
Craig T. Jordan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia

Clinical Trials & Observations
Evan M. Cherry, Diana Abbott, Maria Amaya, Christine McMahon, Marc Schwartz, Julie Rosser, Audrey Sato, Jeffrey Schowinsky, Anagha Inguva, Mohd Minhajuddin, Shanshan Pei, Brett Stevens, Amanda Winters, Craig T. Jordan, Clayton Smith, Jonathan A. Gutman, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2021) 5 (24): 5565–5573.
https://doi.org/10.1182/bloodadvances.2021005538
Published: 2021
Includes: Supplemental data
Journal Articles

Measurement of ex vivo resistance to proteasome inhibitors, IMiDs, and daratumumab during multiple myeloma progression

Clinical Trials & Observations
Zachary J. Walker, Michael J. VanWyngarden, Brett M. Stevens, Diana Abbott, Andrew Hammes, Christophe Langouët-Astrie, Clayton A. Smith, Brent E. Palmer, Peter A. Forsberg, Tomer M. Mark, Craig T. Jordan, Daniel W. Sherbenou
Journal: Blood Advances
Blood Adv (2020) 4 (8): 1628–1639.
https://doi.org/10.1182/bloodadvances.2019000122
Published: 2020
Includes: Supplemental data
Journal Articles

Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia

Clinical Trials & Observations
Amanda C. Winters, Jonathan A. Gutman, Enkhtsetseg Purev, Molly Nakic, Jennifer Tobin, Stephanie Chase, Jeff Kaiser, Lindsey Lyle, Chelsey Boggs, Keri Halsema, Jeffrey T. Schowinsky, Julie Rosser, Mark D. Ewalt, Bradford Siegele, Vishal Rana, Steven Schuster, Diana Abbott, Brett M. Stevens, Craig T. Jordan, Clayton Smith, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2019) 3 (20): 2911–2919.
https://doi.org/10.1182/bloodadvances.2019000243
Published: 2019
Includes: Supplemental data